Qiditangshen Granules, by targeting the GM–SCFA axis and activating receptors such as GPR43, can inhibit overactivation of the renin-angiotensin system (RAS), thereby reducing glomerulosclerosis and tubular injury (123, 126). This evidence concerns the gene FFAR2 and glomerulosclerosis.